Celldex Therapeutics | CLDX - Trade Creditors

Stock Price
30.08
Daily Change
1.54 5.40%
Monthly
30.67%
Yearly
51.31%
Q1 Forecast
28.62

Celldex Therapeutics reported $1.18M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 82.99M 2.3M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Northwest Biotherapeutics 27.22M 5.8M Mar/2025
Pfizer USD 5.02B 142M Sep/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025